Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catalina Orozco

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical & Developmental Immunology|December 13, 2006
Identification of patients with early rheumatoid arthritis: challenges and future directionsCatalina Orozco, Nancy J Olsen
Rheumatic Diseases Clinics of North America|November 10, 2012
Safety of bisphosphonatesCatalina Orozco, Naim M Maalouf
The Journal of Rheumatology|December 17, 2009
Can tumor necrosis factor inhibitors be safely used in pregnancy?Yaser M Ali, Bindee Kuriya, Catalina Orozco, et al.
Arthritis Care & Research|October 4, 2016
Rheumatology Informatics System for Effectiveness: A National Informatics-Enabled Registry for Quality ImprovementJinoos Yazdany, Nick Bansback, Megan Clowse, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical & Developmental Immunology|December 13, 2006
Identification of patients with early rheumatoid arthritis: challenges and future directionsCatalina Orozco, Nancy J Olsen
Rheumatic Diseases Clinics of North America|November 10, 2012
Safety of bisphosphonatesCatalina Orozco, Naim M Maalouf
The Journal of Rheumatology|December 17, 2009
Can tumor necrosis factor inhibitors be safely used in pregnancy?Yaser M Ali, Bindee Kuriya, Catalina Orozco, et al.
Arthritis Care & Research|October 4, 2016
Rheumatology Informatics System for Effectiveness: A National Informatics-Enabled Registry for Quality ImprovementJinoos Yazdany, Nick Bansback, Megan Clowse, et al.
Pageof 1